N/A N=40 Randomized Health Services Research

Text-based Intervention to Minimize the Time Burden of Routine Cancer Care

Cancer · Solid Tumor · Patient Empowerment · Telemedicine

Bottom Line

View on ClinicalTrials.gov: NCT05134636 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2025

Primary outcome: Primary: Healthcare Time — 265.97; 339.54 minutes

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Text triage (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Abramson Cancer Center at Penn Medicine
Primary completion: Dec 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Healthcare Time	265.97; 339.54	—
SECONDARY Total Wait Time	124.79; 154.71	—
SECONDARY Total Number of Hospitalization/Emergency Department Encounters	3; 2	—
SECONDARY Patient Satisfaction as Assessed by the Patient Satisfaction Questionnaire Short Form (PSQ-18)	4.34; 4.5; 4.42; 4.48; 4.19; 4.64	—
SECONDARY Health Related Quality of Life as Assessed by the Functional Assessment of Cancer Therapy-General (FACT-G)	23.21; 23.4; 22.48; 25.71; 17.66; 20.6	—

Summary

The primary objective is to test whether a text-based e-triage can safely minimize the time associated with routine cancer care by identifying patients who can proceed directly to their immunotherapy infusion without a preceding in-person office assessment.

Eligibility Criteria

Inclusion Criteria

Over 18 years of age
Initiating singe agent PDL-1/PD-1 targeted immune checkpoint blockade for any solid malignancy at Penn's Abramson Cancer Center
Access to a mobile phone with texting capabilities
ECOG performance status less than or equal to 2

Exclusion Criteria

Non-English speaking
Unable to perform informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05134636). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.